Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
Clinical trial NCT04575961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04575961
- Sponsor
- North Eastern German Society of Gynaecological Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2026-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.